A radiochemical-high-performance liquid chromatographic assay for urate oxidase in human plasma
โ Scribed by Michael L. Greenberg; Michael S. Hershfield
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 381 KB
- Volume
- 176
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
โฆ Synopsis
Polyethylene
glycol-modified urate oxidase (PEG-uricase) holds promise as a hypouricemic agent for treating gout and as an adjunct to cytolytic therapy of hematologic malignancies. Spectrophotometric assays of urate oxidase are not sensitive enough for pharmacokinetic evaluation of PEG-uricase in clinical trials. We have therefore developed a more sensitive radiochemical-HPLC assay for urate oxidase activity in untreated plasma, in which 14C in urate and in the reaction product, allantoin, is monitored in the uv detector effluent with a flow-through scintillation counter.
The assay is linear with amount of enzyme and time of incubation and can detect <l X lo-' U/ml uricase in plasma. The assay accounts for plasma samples of widely differing urate content.
๐ SIMILAR VOLUMES
A rapid and specific high-performance liquid chromatographic (HPLC) assay for the quantitative determination of tinidazole in human plasma is described. After a simple extraction procedure, the compound is analyzed by HPLC using a reversed-phase column and a UV detector. Quantitation is accomplished